AdvertisementAdvertise with NZME.
Latest fromFisher and Paykel Healthcare
Stock Takes: US stocks rally on Trump win while the rest the world waits
Sharemarket investors are waiting to see how a new US trade policy will play out.
Opinion: Stop losing your marbles over weight-loss wonder drugs
OPINION: Weight-loss drug headlines mask an attractive longer-term picture.
Fisher & Paykel Healthcare ups dividend
Predicted full-year result better than many analysts had been expecting.
Market close: NZ stocks drift as company results fail to inspire
It was another topsy-turvy day for the NZ sharemarket.
Crucial talks imminent in Fisher & Paykel Healthcare industrial action
The chances of averting a strike at a major factory hinge on Wednesday's talks.
Fisher & Paykel Healthcare staff upset at overtime impasse
More than 1500 staff at giant Kiwi firm in dispute over pay, overtime.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Fisher & Paykel’s 30-year master plan requires 'discipline'
The medical device company is on a crusade against 'short-termism'.
Market close: Tourism Holdings leads way after profit turnaround
The New Zealand sharemarket finished the day higher after a late surge.
NZ Inc makes big push in India with business delegation
New Zealand will send one of its largest business delegations to India next week.
Jarden Brief: Meta on a Quest for new VR subscription service
VR attempt to curb the recent trajectory of multi-billion operating loss.
Post-Covid reality check? F&P Healthcare profit drops 34pc
F&P Healthcare's earnings have fallen to more normal levels after a big Covid-surge.
Who’s in the running to handle possible Auckland Airport share sale?
Meanwhile, details emerge of Virgin Australia's re-listing plans.
Markets with Madison: Analysts eyeing Fisher & Paykel hit, upside for aged care
FPH is extraordinarily overvalued, Forsyth Barr says.
Jarden Brief: Chip war heats up as US-China competition sparks strict new rules
Restrictions part of US effort to impede Beijing’s ambitions while ensuring stable supply.
F&P Healthcare shares soar on revenue guidance
Flu season and China Covid outbreak boosts demand.
Market close: NZ stocks rise on back of big Wall St turnaround
An energetic Fisher and Paykel Healthcare led the way.
Fisher & Paykel Healthcare to spend $275m on Karaka land for campus
"We need more space": Mega-development will roll out over decades.
F&P Healthcare expects sharp first half profit fall, shares plummet
F&P Healthcare sees earnings returning to pre-Covid levels in the first half to September.
Covid-19 had a profound impact on F&P Healthcare, says CEO
Fisher & Paykel Healthcare's net profit dropped by 28 per cent to more normal levels.
F&P Healthcare net profit drops 28pc
The healthcare manufacturer withholds guidance for current year.
Result preview: What to expect from F&P Healthcare
F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.
Market close: Investors offload Ryman, F&P Healthcare shares
The New Zealand sharemarket opened the week with more than a 1 per cent fall.
F&P Healthcare share price drops after revenue guidance
The previous year's revenue came to $1.97b.
Deloitte Top 200 Award finalists named
The best of business in New Zealand set to be honoured in the annual Top 200 awards.